Amount Further Needed to be Raised in 2021
The 2021 Goal for the "Campaign for Cures" is to Support Research for Developing COVID-19 Vaccines and Therapies and Advance Stem Cell Treatments for the Institute's Therapeutic Priorities
The "Campaign for Cures" has advanced to the next level to develop ethical human cell lines that can be used in the bio-manufacturing of vaccines, protein therapeutics, gene therapy and cell therapy. The Institute has achieved incremental research milestones. For 2020 fiscal year, the "Campaign for Cures" has raised funding to complete Phase 1 of our COVID-19 vaccine. The objectives for 2021 is to raise $750,000 to help defray the cost of conducting preclinical animal testing of the Institute's first vaccine candidate. For 2021, we have raised $175,000 of our goal of $750,000. Additionally, these funds will also be used to also cover the research costs to advance adult stem cell research for our Therapeutic Priorities. The funds raised by the "Campaign for Cures" has achieved important research milestones. These research milestones will lead to future coronavirus vaccines that will be designed, manufactured and tested free of aborted fetal cells and will offer scientific advantages. The Institute has the technical resources and expertise to offer solutions, but it needs financial support from individuals and organizations. Please join this important campaign by making a meaningful, tax-deductible contribution and earmark your donation towards our "Campaign for Cures" program. To learn more about our "Campaign for Cures" for developing a COVID-19 vaccine, go to this link. We have provided a link to address the frequently asked questions regarding the Institute's COVID-19 vaccine research program.
The Institute needs physicians to volunteer to identify and recruit patients to participate in obtaining tissue samples from patients to create induced pluripotent stem (IPS) cells.
The John Paul II Medical Research Institute (JP2MRI) focuses on the most ethical and cost-effective way of conducting medical research to help develop therapies and cures for a variety of diseases. Most diseases share a common technical requirement to create therapies. The Institute’s research focuses on these common technical requirements by recruiting patients to procure tissue to develop stem cells and cancer cells for medical research.
The Institute differentiates itself from other research organizations in the following manner:
1. We do NOT support embryonic stem cell research. We support research that is pro-life driven.
2. We devote more than half of our budget towards medical research, which is far greater than most established foundations.
We need your support now.
This is a patient registry form for anyone who has a genetic disorder who would like to join. All data will be held confidentially, obtained voluntarily, and will never be shared with third parties. Once you're done, click Submit.